280: ESMO highlights, Roivant's big deal, & biotech VC on the rise
26 Oct 2023
29m
STAT · Science
The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
279: Live from the 2023 STAT Summit
19 Oct 2023
33m
278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
12 Oct 2023
32m
277: Is the Nobel committee evolving? Plus, preventing public health's wiliest virus
05 Oct 2023
31m
276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump
28 Sep 2023
34m
275: A thorny ALS debate at the FDA, and the promise of artificial wombs
21 Sep 2023
33m
274: Covid’s latest surge, Alnylam at the FDA, & the end of an era
14 Sep 2023
39m
273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter
07 Sep 2023
33m
272: Vivek's star turn, leaky drug data, & biotech as family business
24 Aug 2023
29m
271: Racing for gene therapy, a pioneering approval, & startups in the lurch
18 Aug 2023
34m
270: Your guide to Wegovy’s blockbuster heart study
10 Aug 2023
32m
269: Biotech layoffs, eye drug drama, & gene therapy milestones
03 Aug 2023
37m
268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading
27 Jul 2023
36m
267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford
20 Jul 2023
35m
266: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads
13 Jul 2023
32m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.